RSS

TEPI Patch

Drug delivery company Medherant has announced that it has successfully completed two Phase I studies focusing on its Ibuprofen TEPI Patch. Read more

News

A spinout company from the University of Warwick has gained £2.5 million of investment for its drug delivery patch technology. Read more

News